ENTO
Entero Therapeutics
ENTO
ENTO
11 hedge funds and large institutions have $106K invested in Entero Therapeutics in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
82% less capital invested
Capital invested by funds: $601K → $106K (-$495K)
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$15.4K | |
| 2 | +$15K | |
| 3 | +$9K | |
| 4 |
Goldman Sachs
New York
|
+$6K |
| 5 |
VF
Virtu Financial
New York
|
+$4K |
Top Sellers
| 1 | -$227K | |
| 2 | -$12K | |
| 3 | -$11K | |
| 4 |
WIA
World Investment Advisors
Santa Barbara,
California
|
-$11K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$6K |